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WHAT THIS PAPER ADDS?
 Atherosclerotic plaques from distinct anatomical locations exhibit differences in their cellular and biochemical composition and
importantly the proportion of inﬂammatory macrophage subsets.
 Compared to femoral plaques from patients with chronic limb ischemia, symptomatic carotid lesions exhibit increased lipid and
inﬂammatory cell inﬁltration, a greater proportion of M1-like pro-inﬂammatory macrophages, and a decreased proportion of
atheroprotective M2-cells.
 Identiﬁcation and evaluation of more speciﬁc drug therapies which target M1-type macrophages in symptomatic carotid disease
could prove to be a valuable therapeutic intervention.a r t i c l e i n f o
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Objective: To compare differences in macrophage heterogeneity and morphological composition between
atherosclerotic plaques obtained from recently symptomatic patients with carotid artery disease and
femoral plaques from patients with severe limb ischemia.
Design: Experimental study.
Methods: Plaques were obtained from 32 patients undergoing carotid endarterectomy and 25 patients
undergoing common femoral endarterectomy or lower limb bypass. Macrophages and T cell numbers
were detected in plaque sections by immunohistochemistry and anti CD68 and CD3 antibodies. Dual
staining for CD68 and M1- and M2-macrophage markers and morphometric analysis of hematoxylin and
eosin stained plaque sections was performed.
Results: Carotid plaques had signiﬁcantly increased percentage areas of conﬂuent lipid and leukocytic
inﬁltrates. In contrast, areas of ﬁbroconnective tissue were signiﬁcantly greater in femoral plaques and
percentage areas of conﬂuent calciﬁcation and collagenwere elevated. Carotid artery plaques had greater
numbers per plaque area of macrophages and T cells consistent with a more inﬂammatory phenotype.
Proportions displaying M1-activation markers were signiﬁcantly increased in the carotid compared to
femoral plaques whereas femoral plaques displayed a greater proportion of M2-macrophages.
Conclusion: Plaques from patients with recently symptomatic carotid disease have a predominance of
M1-macrophages and higher lipid content than femoral plaques, consistent with a more unstable plaque.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Atherosclerosis is a systemic inﬂammatory disease character-
ized by the formation of atheromatous plaques within arteries.1
These plaques can be classiﬁed as rupture prone and unstable as
characterized by a necrotic lipid core, increased inﬂammatory cell: þ44 1224 437348.
son).
ciety for Vascular Surgery. Publisheinﬁltrate and reduced ﬁbrous cap thickness, or stable and ﬁbrous
with little lipid and inﬂammatory inﬁltrate and increased cap
thickness.2 The presence of inﬂammatory cells and notably
macrophages within plaques has long been associated with plaque
destabilization, rupture and thrombosis.3 Recent interest has
focussed on the heterogeneous role of inﬂammatory macrophages
in the initiation, progression and vulnerability of atherosclerotic
lesions.3e6 Macrophage heterogeneity and broad ranging functions
are dictated by microenvironmental stimuli.4,7 Classically activated
or M1-macrophages have anti-microbial and tissue-destructived by Elsevier Ltd. All rights reserved.
Figure 1. Schematic presentation of segmentation of the endarterectomy specimen.
Plaques were cut into 7 segments of 2e3 mm in thickness depending on the size of
plaque. For carotid plaques, segment 0 was taken as the last complete transaction of
the common carotid artery at its bifurcation. For femoral plaques segment 0 represents
the area of maximum stenosis, taken as the center of the plaque. Segments 3,
0 and þ2 was further sectioned for histological and immunohistochemical analysis.
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and reactive oxygen and nitrogen species, metalloproteinases and
tissue factor that are associated with plaque destabilization,
rupture and thrombosis.4e7 Alternatively activated or M2-
macrophages are anti-inﬂammatory, tissue-reparative, immuno-
suppressive and reduce inﬂammation by clearing apoptotic cells
and tissue debris. In established plaques, it is proposed thesewould
principally be anti-atherogenic and enhance plaque stability.4e8 In
atherosclerosis, other characteristic subsets e.g. Mox macrophages
are becoming recognized9 and the contribution of macrophages to
plaque stability and clinical outcome will be inﬂuenced by the
balance of the distinct subtypes present.4e6
Plaques within the internal carotid artery territory often
thrombo-embolise, resulting in stroke, transient ischemic attacks
andamaurosis fugax.2 Plaqueswithin femoral arteriesoften give rise
to ﬂow-limiting symptoms such as intermittent claudication, rest
pain, ulceration and gangrene. It might be expected that plaques
which had been associated with a recent thrombo-embolic event
would exhibit greater biochemical and compositional features of
instability and more inﬂammatory, destabilizing macrophages, as
compared to plaques which were associated predominantly with
stable ﬂow-limiting symptoms, although evidence in the literature
to support this contention is scanty and even conﬂicting.10e12
Recognizing the types and roles of inﬂammatory macrophages
within atheromatous plaques and how they relate to plaque
composition or stability is important to understand the patho-
genesis of lesions and may have signiﬁcant implications for both
imaging vulnerable plaques and tailoring appropriate therapy. This
study was designed to fully evaluate the morphological composi-
tion of atherosclerotic plaques from recently symptomatic patients
with carotid disease and femoral plaques from patients with severe
limb ischemia, focusing on the differences in subsets of inﬂam-
matory macrophages.
Materials and Methods
Patients
Thirty two consecutive patients presenting with symptomatic,
signiﬁcant carotid stenosis (>50% stenosis according to the NASCET
criteria)13 and 25 patients presenting with severe limb ischemia
and signiﬁcant stenosis of either the common femoral arteries (23
patients) or the superﬁcial femoral arteries (2 patients), which
were due to undergo surgery, were recruited. Ethical approval was
obtained from the North East of Scotland Ethical Committee.
Informed written consent was obtained from all patients. All
patients underwent secondary prevention therapy according to
National guidelines (Scottish Intercollegiate Guidelines network)
for the treatment of symptomatic cerebrovascular disease and
peripheral arterial disease.14,15
Plaque processing and histopathology
The excised carotid or femoral endarterectomy specimens were
cut into 7  2e3 mm segments as shown in Fig. 1. Pre-deﬁned
segments were designated for both histology and immunohisto-
chemistry and ﬁxed in 5% phosphate buffered formaldehyde. After
decalciﬁcation in 5% formic acid for 24 h, the sections were
embedded in parafﬁn.
Histopathology and plaque morphometry
Hematoxylin and eosin stained sections of plaque were
analyzed using the modiﬁed American Heart Association (AHA)classiﬁcation16 by an experienced consultant pathologist (PAJB)
blinded to the clinical data.
Morphometric analysis of hematoxylin and eosin stained plaque
sections was based on criteria from published studies17 and per-
formed by an experienced pathologist (RL) blinded to the clinical
data. The total plaque area was measured in each plaque by
captured digital images and tracing around the perimeter of
conﬂuent areas. Conﬂuent zones greater than 0.02 mm2 of (i) lipid,
(ii) calciﬁcation, (iii) ﬁbroconnective tissue in which occasional
scattered lymphocytes, lipid laden macrophages or spotty calciﬁ-
cation (deﬁned as ﬁbroconnective tissue) and (iv) ﬁbroconnective
tissue with obvious lymphocytic or mixed lymphocytic and
macrophage cellular inﬁltrate, were determined. These conﬂuent
zones were classiﬁed as illustrated in Fig. 2. Measurements were
expressed as mm2. Collagen content was determined after
Picrosirius red staining. Areas were deﬁned as percentage areas of
the total endarterectomy specimens so that relative proportions of
the components in each plaque were comparable. The intra-
observer variation was <3%. In all cases the median value from
sections 3, 0 and þ2 is reported.Cellular composition: immunohistochemistry
Sections from the 3 areas of plaque (3, 0 and þ2) were
deparafﬁnized and dehydrated followed by microwaving in citrate
buffer (pH 6.0) for antigen retrieval and endogenous peroxidase
activity quenched with 3% (vol/vol) H2O2 in methanol. Plaque
sections were batch stained using a Dako autostainer. Macrophages
and T-cells were detected by anti-CD68 (KP1) and anti-CD3
(F7.2.38) antibodies (Dako, Ely, UK) respectively, and the DAKO
Envision Detection Kit K5007. Speciﬁc brown staining was devel-
oped by incubation with Chemate diaminobenzidine (Dako). Slides
were counterstained with hematoxylin and nuclei blued with Scots
Table 1
Baseline demographics of patients with symptomatic carotid and femoral artery
disease. Values show number of patients and percentage (%) in each group.
Carotid
plaques
(n ¼ 32)
Femoral
plaques
(n ¼ 25)
P
Patient details
Median age (IQR) years 69(48e83) 71(56e78) 0.51
Number of males (%) 21(66%) 18(72%) 0.78
Co-morbidities (%)
Diabetes 7(22%) 6(24%) 0.99
Hypertensiona 30(94%) 21(84%) 0.39
Coronary heart disease
(Angina, MI)
14(44%) 16(64%) 0.18
Smoking 16 (50%) 23(92%) 0.001
Medication
Cholesterol lowering therapy 32(100%) 25(100%) 1.0
Anti-platelet therapy 32(100%) 25(100%) 1.0
Anti-hypertensive therapy 12(38%) 15(60%) 0.11
Symptoms (number of patients)
Transient ischemic attack 16(50%)
Cresendo TIA 3(9%)
Cerebrovascular accident 9(28%)
Amaurosis fugax 4(13%)
Short distance intermittent
claudication
9(36%)
Rest pain 11(44%)
Ulceration/gangrene 5(20%)
Duplex detected ipsilateral
internal carotid artery
stenosis; median (IQR)
80%(70e99%)
Ipsilateral ankle brachial
pressure index median
of highest value (IQR)
0.52(0e0.95)
a Hypertension is deﬁned as a history of systolic pressure >140 mmHg or a dia-
stolic pressure >90 mmHg upon at least three repeated measurements.
Figure 2. Morphological characterization of plaques was deﬁned by four categories. Lipide obvious conﬂuent areas of lipid depositionwhether intra- or extra-cellular. Calciﬁcation e
obvious measurable areas of conﬂuent calciﬁcation. Fibroconnective tissue e obvious conﬂuent areas of ﬁbroconnective tissue depositionwith no conﬂuent areas of calciﬁcation, lipid
or lymphocytic inﬁltration. Fibroconnective tissue with obvious lymphocytic/macrophage cellular inﬁltratee obvious conﬂuent areas of ﬁbrointimal changewith obvious lymphocytic or
lymphocytic and macrophage inﬂammation throughout the area. Outlines in dashed lines encircle conﬂuent zones of lipid (A), calciﬁcation (B), lymphocytic and macrophage inﬁl-
tration (C), and ﬁbroconnective tissue present in A, B and C as highlighted by asterisks. Theseweremeasured by tracing around the perimeter of conﬂuent abnormality and subsequent
image analysis. In Fig. 1B, an example of spotty non-conﬂuent calciﬁcation (black arrow) is also present. This spotty calciﬁcation would be designated within the “ﬁbroconnective
tissue” category and not included within areas designated as conﬂuent calciﬁcation. Original magniﬁcation (A) 200, (B & C) 400.
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for stainingwith anti-CD68 and theM2-macrophagemarkers6,18e20
dectin-1 (R&D Systems, Abingdon, UK), SOCS1 (Abcam, Cam-
bridgeshire, UK) and CD163 (AbD Serotec, Kidlington, UK) and the
M1-macrophagemarkers,4,6,18 inducible nitric oxide synthase, iNOS
(BD Biosciences, Cambridge, UK), MHC class II (Dako) and SOCS3
(Abcam), according to the manufacturer’s instructions; positive
staining was detected using diaminobenzidine/liquid Permanent
Red (Dako). A negative control where the primary antibody was
replaced by a non-speciﬁc IgG equivalent was included in all
analyses.
Quantiﬁcation of T-cell and macrophage counts
Intact CD68-positive cells with well-deﬁned cytoplasm and
nuclei were counted in the entire plaque to obtain the absolute
counts. Counts were repeated until 3 consecutive values were ob-
tained with a margin of error of 10 cells and an average taken as
the absolute macrophage count. The area of the plaque was esti-
mated in mm2 by photographing the plaque under a dissecting
microscope at 0.75 and using “Volocity” image analysis software
(PerkinElmer Life and Analytical Sciences, Inc). Absolute counts
were then divided by the plaque area to obtain the intact macro-
phage counts per mm2. A similar technique was used to count the
CD3-positive T-cells per area. Both the intra-observer and inter-
observer variation were found to be less than 5% (P < 0.002).
Double stained sections were analyzed using bright-ﬁeld light and
positivity for liquid permanent red conﬁrmed using rhodamine
ﬂuorescent microscopy. Macrophage-rich clusters within the pla-
quewere identiﬁed and on average greater than ﬁfty CD68-positive
cells were counted. The number of these cells which were double
positive was counted and expressed as a percentage of total
macrophages. Preliminary quantiﬁcation by two independent
observers conﬁrmed that the proportions of M1/M2 macrophages
in macrophage-rich areas were not signiﬁcantly different from the
proportions estimated from total macrophage counts.
Statistical analyses
Comparison of demographic data was assessed by the Fisher’s
exact test or two sample Student’s t-test. The Mann Whitney U test
was used to compare the CD68 counts/mm2, CD3 counts/mm2, and
morphological differences between the carotid and the femoral
plaques. A Kruskal Wallis test was used to compare the markers of
M1- and M2-activated macrophages between the carotid and
femoral plaques. All values are reported as medians and inter-
quartile ranges. Correlations were performed by Spearman’s
method.Results
Population characteristics
The demographic characteristics and risk factors proﬁle for the
patients undergoing carotid surgery and femoral artery surgery are
shown in Table 1. Comparison of the two groups revealed no
statistical differences in terms of age, gender, diabetes, hyperten-
sion, coronary heart disease, cholesterol lowering or anti-platelet
therapy. A signiﬁcantly higher proportion of patients who had
femoral disease admitted to being smokers and were on anti-
hypertensive therapy. All but one of the patients was on statin
therapy. The median duration of statin therapy prior to surgery for
the patients with symptomatic carotid disease was 4 weeks
(interquartile range (IQR) 3e20 weeks). Four of these patients had
Table 2
Differences between carotid and femoral plaque morphometry. Conﬂuent areas
were determined by morphometry as described in Materials and methods. Values
show median area or counts/mm2 and interquartile range in brackets from
sections 3, 0 and þ2. * marks statistically signiﬁcant differences in area compo-
sition between femoral and carotid plaques.
Conﬂuent area (mm2) Carotid plaques Femoral plaques P value
Lipid 2.63 (0e15.29) 0.184 (0e0.92) 0.012*
Calciﬁcation 0.19 (0.01e13.62) 11.14 (0.75e27.40) 0.143
Fibroconnective tissue 12.60 (0.15e57.39) 69.67 (34.7e98.93) 0.002*
Fibroconnective tissue
with cellular inﬁltrate
64.60 (11.5e87.37) 1.04 (0e39.32) 0.002*
Macrophage counts 39.76 (34.20e49.96) 13.20 (7.80e21.13) 0.001*
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and were on statin therapy at the time of their recent cerebrovas-
cular event. The median time between index symptoms and carotid
surgerywas 4weeks (IQR 2e10weeks). Themajority of the patients
with femoral artery disease had been on statin therapy long term,
apart from two which were started 6 weeks prior to surgery. The
median duration of statin therapy prior to surgery for the patients
with femoral artery disease was 66 weeks (IQR 52e105 weeks). All
patients with femoral artery disease had been on anti-platelet
therapy long term with mean duration prior to surgery 23
months (IQR 2e94months) while for thosewith carotid disease the
mean duration before surgery was 2 months (IQR 1e53 months).
Femoral and carotid endarterectomy specimens display different
histopathology and plaque morphometric characteristics
All carotid and femoral plaque specimens were classiﬁed as
unstable according to the modiﬁed AHA classiﬁcation.16 The
majority of lesions were classed as grade IV lesions in the three
anatomical sections studied from each case. Grade IV lesions wereFigure 3. Carotid artery plaques show signiﬁcantly higher numbers of total CD3-positive T ce
plaques (denoted by arrows). Box plots show the median numbers of cells per area (mm2)
range (IQR) and the whiskers represent the range (95% conﬁdence interval). The circles are
3IQRs from the end of a box. The three bars within carotid or femoral plaque groups repr
bifurcation and section þ2 representing 1 section proximal to the bifurcation, as describeddeﬁned as a plaque with a lipid or necrotic core surrounded by
ﬁbrous tissue with possible calciﬁcation. In four of the carotid
plaques, and one of the femoral plaques, luminal thrombosis was
present (grade VI).
Conﬂuent zones of plaque were deﬁned by morphometry as in
Fig. 2. The percentage area occupied by conﬂuent lipid and areas
with marked lymphocytic and monocyte/macrophage inﬁltrates
were signiﬁcantly greater in carotid plaques as compared to that of
femoral plaques (Table 2). In contrast, areas of ﬁbroconnective
tissue were signiﬁcantly greater in the femoral plaques. The
percentage area of conﬂuent calciﬁcation was elevated but was not
statistically greater in the femoral plaques. The percentage area of
collagenwas signiﬁcantly greater in femoral plaques, (median (IQR)
48.2% (30.1e66.8) versus 32.6% (21.2e44.9); ManneWhitney U test,
P < 0.01).Numbers of macrophages and T-cells per plaque area differ between
femoral and carotid endarterectomy specimens
There was no signiﬁcant difference between the total
numbers of CD68-positive macrophages or CD3-positive T-cells
in each of the three segmental sites assessed within the carotid
or femoral plaques (Fig. 3A and B) reﬂecting plaque homoge-
neity. The CD68-positive intact macrophage counts were signif-
icantly higher in carotid as compared to femoral plaques,
consistent with morphometric analysis, (median (IQR) 39.76
(34.2e49.96) versus 13.20 (7.8e21.13) counts per mm2; Kruskal
Wallis test, P < 0.001), Fig. 3. Likewise, the CD3-positive T-cell
counts per mm2 were signiﬁcantly higher in carotid plaques,
(10.62 (7.89e13.67) versus 3.15 (2.0e5.7); Kruskal Wallis test,
P < 0.001).lls (A) and total CD68-positive macrophage (B) per unit area than that of femoral artery
of carotid (n ¼ 32) and femoral (n ¼ 26) plaques. The box represents the inter-quartile
outliers which are 1.5 IQR from the end of the box and the stars are outliers which are
esent stained section 0 at the bifurcation, section 3 representing 2 sections distal to
in Materials and methods. Original magniﬁcation for Figures 200.
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between femoral and carotid endarterectomy specimens
M1-macrophages
The median percentage of iNOS-positive, CD68-positive M1-
macrophages was signiﬁcantly increased in the carotid compared
to femoral plaques (median (IQR) 79% (72e83) versus 58% (51e62);
Kruskal Wallis test; P < 0.001) as was the median percentages of
MHC class II-positive, CD68-positive macrophages (74% (71e81)
versus 40% (34e48); P < 0.001), Fig. 4. The percentages of SOCS3-
positive, CD68-positive macrophages were also signiﬁcantly
increased in the carotid compared to the femoral plaques (76% (71e
82) versus 44% (30e54); P < 0.001).
M2-macrophages
The median percentage of dectin-1-positive, CD68-positive M2-
macrophages was signiﬁcantly decreased in the carotid compared
to femoral plaques, (median (IQR) 22% (15e33) versus 52% (46e
57); P < 0.001) as were the percentages of CD163-positive, CD68-
positive macrophages (26% (17e35) versus 60% (55e76);
P < 0.001). Similarly, the percentages of SOCS1-positive, CD68-
positive M2-macrophages were signiﬁcantly decreased in the
carotid compared to femoral plaques (16% (9e28) versus 42% (36e
53); P < 0.001).
Correlation between immunohistochemistry and morphometry
The maximum number of CD68-positive macrophage counts
correlated negatively with the median percentage area of ﬁbro-
connective tissue for the three sections examined (Spearman’s
correlation; Rs ¼ 0.282; P ¼ 0.039) and collagen (Rs ¼ 0.447;
P ¼ 0.001) but positively with ﬁbroconnective tissue with obvious
lymphocytic cellular inﬁltrate (Rs ¼ 0.332; P ¼ 0.014). No signiﬁ-
cant correlation was observed between total macrophage counts
and percentage area of lipid core or calciﬁcation.
The expression of M1-macrophage markers correlated with
ﬁbroconnective tissue with obvious cellular inﬁltrate, (Rs ¼ 0.379;
P ¼ 0.005) and the correlation was greater than that of total macro-
phages, whereas M2-markers exhibited a negative correlation
(Rs¼0.292;P¼0.033). In contrast to totalCD68þmacrophages, the
percentage of M1-markers correlated signiﬁcantly with the propor-
tion area of conﬂuent lipid (Rs¼ 0.353; P¼ 0.03) and the percentage
of M2-markers correlated signiﬁcantly with areas of calciﬁcation
(Rs¼ 0.304; P¼ 0.031).Within the carotid and femoral plaques there
was no signiﬁcant correlation between the total numbers of CD68-
positive macrophages and duration of statin therapy (weeks).
However, proportions of M1 macrophages showed a signiﬁcant
negative correlation with duration of statin therapy (Rs ¼ 0.506,
P < 0.001) while M2 macrophages showed a positive correlation
(Rs ¼ 0.493, P < 0.001). By contrast, there was so signiﬁcant corre-
lation between total numbers of macrophages or proportion of
macrophage subsets and the duration of anti-platelet therapy.
Discussion
This study has demonstrated important associations of the
percentage of M1- and M2-macrophages with compositional
features of the plaque that, to date, have been lacking in human
atherosclerosis studies.21,22 Carotid and femoral plaques exhibit
substantially different cellular and morphological compositions as
may be anticipated from their location and clinical presentations.
By using a panel of markers and co-staining for CD68 positive cells
we show a greater preponderance of M1-macrophages within
carotid compared to femoral plaques and relate this to morpho-
metrically measured plaque components.M1-macrophages are considered to have a potential role in
atherogenesis and plaque instability due to their high expression of
metalloproteinases, cytokines, bioactive lipids and tissue destruc-
tive nitrogen and oxygen radicals.4e6 Consistent with the greater
proportion of M1-macrophages in carotid plaques, we show, using
detailed morphometric analysis, that carotid plaques exhibit
signiﬁcantly greater percentage areas of conﬂuent lipid and
immune-cell inﬁltrate and show reduced cap thickness compared
to femoral plaques. These features suggest that M1-macrophages
are a further identiﬁable feature of the unstable plaque.
M2-macrophages have potential to promote tissue reparative
processes and enhance plaque stability due to their well reported
immunoregulatory, reparative phenotype and ability to promote
collagen synthesis.4e6,23 In line with this we show a greater
percentage area of collagen in M2-macrophage rich femoral pla-
ques than in M2-macrophage poor carotid plaques. For femoral
plaques, percentage areas of collagen and ﬁbroconnective tissue
were signiﬁcantly increased and conﬂuent calciﬁcation tended to
be higher. Plaques from both the common and superﬁcial arteries
were included in the femoral group. Plaque composition between
the two is reported to differ24 yet when analyzed together in our
study, the composition was still signiﬁcantly different from that of
symptomatic carotid plaques. Femoral plaques have previously
been reported to exhibit signiﬁcantly more calciﬁcation than
carotid plaques12 and increased levels of plaque calciﬁcation has
been observed in asymptomatic as compared to symptomatic
carotid plaques.25 We would suggest that the presence of calcium
within plaques relates to stable plaques rather than deﬁning
unstable plaques, as suggested previously.26
M1- and M2-macrophage markers in single stained sections has
been previously demonstrated in distinct locations of lipid-rich
human carotid atherosclerotic lesions.21 However, MCP-1, the
only M1-marker used in this previous study, is not speciﬁc to
macrophages and is largely secreted. Moreover, no correlations
were performed on proportions of M1- or M2-macrophages and
plaque phenotype, and lipid poor plaques were not evaluated. The
current study is the ﬁrst to deﬁnitively characterize macrophage
phenotype by the co-localization of CD68-positive cells with
a panel of M1- and M2-macrophage markers which is critical for
a speciﬁc and comprehensive analysis of the proportion of
macrophage types within the plaque. This is not possible by total
mRNA or protein levels in plaque that would be strongly dependent
on the number of macrophages present in tissue and expression
levels by cells other than macrophages. Importantly, correlations
between M1-macrophages and morphological parameters linked
to plaque instability (lipid, lymphocytic cellular inﬁltrate) or M2
macrophages and features of stability (calcium, ﬁbroconnective
tissue)2 was more highly signiﬁcant than correlations with total
macrophage counts across all plaques studied. This supports the
view that the proportion of macrophage subsets within plaques is
a better predictor of the compositional phenotype and related
stability of plaque as compared to total macrophages.
The difference in duration of statin therapy between patients
with carotid and femoral disease is a confounding variable and
could account for some decrease in lesion inﬂammation in femoral
plaques. Total macrophage counts within plaques did not correlate
signiﬁcantly with the duration of time the patient was on statin
therapy, yet, we show for the ﬁrst time, a signiﬁcant negative
correlation between duration of statin therapy and proportion on
M1-macrophages. There is no evidence that statins can switch
plaque macrophages from an M1 to an M2 phenotype but they
could inﬂuence the initial polarization to M2 by dampening the
inﬂammatory environment.27,28 Anti-platelet therapy could also
exert beneﬁcial effects on the inﬂammatory composition of human
atherosclerotic carotid plaques but we did not ﬁnd a correlation
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their subsets in our study.
In summary this study has shown a relationship between the
phenotype of macrophages subsets and the compositional markers
of plaque stability in two distinct anatomical atherosclerotic arte-
rial beds. In future studies it would be of value to compare
macrophage subsets in symptomatic versus asymptomatic plaques.
It may also be of value to develop ligands against M1-macrophages
for positron emission tomography (PET) imaging with the aim of
non-invasively identifying the unstable plaque.
Appendix A. Supplemental material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ejvs.2012.08.005
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